Evaluation of the validity of Hb A2 and mean corpuscular haemoglobin action values in antenatal screening for beta thalassaemia carriers in England

被引:1
|
作者
Daniel, Yvonne [1 ]
Cartwright, Ronwyn [2 ]
Rennie, Kristian [3 ]
Streetly, Allison [4 ]
Howard, Jo [2 ]
机构
[1] Guys & St Thomas Hosp, Red Cell Ctr, GSTS Pathol, London SE1 9RT, England
[2] Guys & St Thomas Hosp, Dept Haematol, London SE1 9RT, England
[3] Univ Coll London Hosp, London, England
[4] Kings Coll London, Dept Primary Care & Publ Hlth Sci, London, England
关键词
beta thalassaemia carrier; action values; antenatal screening;
D O I
10.1111/bjh.12917
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
National antenatal screening of all pregnant women in England is carried out using standards and guidelines produced by the National Health Service Sickle Cell and Thalassaemia Screening Programme. The algorithms for detection of beta thalassaemia carrier status rely on action criteria, which are set using the percentage Hb A(2) and mean corpuscular haemoglobin (MCH) values. Three groups of samples: MCH <27 pg and Hb A(2) 3.5-3.9%, MCH >= 27 pg and Hb A(2) 4-4.3% and MCH >= 27 pg and Hb A(2) 3.5-3.9% were selected from a sample population of 59 500 to assess the validity and predictive value of the action criteria - 25 false positives (0.042% of total) and nine false negatives (0.015% of total) were detected. These findings support the continuation of the current action values.
引用
收藏
页码:607 / 611
页数:5
相关论文
共 4 条
  • [1] Evaluation of the validity of UK NEQAS Hb A2 data for the NHS Sickle Cell and Thalassaemia Screening Programme
    Batterbee, H.
    De la Salle, B.
    Wild, B.
    McTaggart, P.
    Dore, C.
    Porter, N.
    Hyde, K.
    BRITISH JOURNAL OF HAEMATOLOGY, 2010, 149 : 57 - 57
  • [2] Evaluation of the validity of UK NEQAS Hb A2 data for the NHS sickle cell and thalassaemia screening programme
    Batterbee, H.
    De la Salle, B.
    Wild, B.
    McTaggart, P.
    Dore, C.
    Hyde, K.
    BRITISH JOURNAL OF HAEMATOLOGY, 2009, 145 : 56 - 56
  • [3] EVALUATION OF A PRENATAL SCREENING-PROCEDURE FOR BETA-THALASSEMIA CARRIERS IN A CHINESE POPULATION BASED ON THE MEAN CORPUSCULAR VOLUME (MCV)
    GHOSH, A
    WOO, JSK
    WAN, CW
    MACHENRY, C
    WONG, V
    MA, HK
    PRENATAL DIAGNOSIS, 1985, 5 (01) : 59 - 65
  • [4] Effect of antiretroviral therapy on hemoglobin A2 values can have implications in antenatal beta-thalassemia screening programs
    Bhagat, Priyanka
    Sachdeva, Ravinder Kaur
    Sharma, Prashant
    Sachdeva, Man Updesh Singh
    Chhabra, Sanjeev
    Sharma, Aman
    Das, Reena
    INFECTIOUS DISEASES, 2016, 48 (02) : 122 - 126